Acumen Research & Consulting estimates that global Organ Transplantation market is expected to reach the market value of around US$ 6.7 Bn by 2028 and is anticipated to grow at a CAGR of around 9.9% in terms of revenue during the forecast period 2021 - 2028.
Organ transplantation remains one of the biggest milestones of medical medicine. Organtransplantation is a procedure totransplantthe organ such as liver, heart, pancreas and others from one body to the other to restore the missing or injured tissue. The approval of the recipient or the recipient's family is one of the most significant aspects of organ transplantation. Organ mining is unethical and a major felony without prior authorization. Heart transplantation is usually done by a dead brain donor who is stable with certain organs that can be used to save someone else's life. Upon the death of the patient, the transplantation of the organ must take place within a few hours.. The kidney organ is the most frequently transplanted, followed by the liver. Unfortunately, the percentage of individuals losing organs is even higher than organ transplantations. According to the National Kidney Foundation, more than 3,000 new patients are added to the list of waiting kidneys worldwide every month. According to the United Network for Organ Transplantation, 21 people in the United States die every day in search of an organ..
The report provides analysis of global Organ Transplantationmarket for the period 2017-2028, wherein 2021 to 2028 is the forecast period and 2020 is considered as the base year.
Market Insights
A major contributor to consumer development is the increasing need of new medicines for organ transplantation for the treatment of organ failure. Organ failure is usually due to a number of causes such as extreme injuries, organ loss, overdose, alcohol dependence, pneumonia, sepsis, etc. The demand for tissue and transplantation is very high, especially in the kidneys, heart, liver and lungs. Four of the major causes of organ failure are poor eating patterns, lack of exercise, alcohol consumption, and substance abuse. Acute disease can often lead to increased cases of organ failure. According to the United States, there were approximately 122,913 people with criteria for organ transplantation in the Department of Health & Human Services in America in 2020. This will fuel market growth due to the high demand for advanced transplantation products. In addition, the launch of high-tech products and an increase in the number of tissue banks will fuel market growth.
However, a large number of people do not want transplantations because they lack awareness about organ transplantations and social stigma. The shortage of organs for diagnosis of organ failure would therefore have a detrimental effect on the development of the market. The demand for and supply of organs for diagnosis of organ failure is enormously different. Similar to the United States In 2020, there were approximately 43,201 people with renal transplantation needs in the U.S. Department of Health & Human Services; however, only 23,401 renal transplantation operations were completed.
Regional Stance
North America dominates the global market for organ transplantation. Rising prevalence of organ failure, increasing advances in the medical sector, well-developed health services and higher health spending are contributing to the growth of the American market.In the past decade there has been a worsening gap between demand and the supply of organ including kidneys, liver and heart. Governments and NGOs from different countries, however, undertake initiatives to encourage people to donate organs and save lives. The donation process is made more straightforward and simpler with updated standards and regulations on organ donation. The Hospital Organ Donor Campaign started in April 2020 by the Human Resources & Services Administration. As a result, organ donations from the previous year have risen.
The Asia-Pacific region is the fastest growing region in the world. Emerging markets and an increasing population of chronic diseases are key factors for the Asia-Pacific industry.
End Use Stance
Hospitals retained the largest market share in 2020 due to the increase in the number of organs and tissue transplants in hospitals as primary treatment centers, maintaining its dominant position during the forecast period. In addition, existing infrastructure hospitals are projected to build and drive growth in demand.
During the forecast era, the transplant center section is projected to show the significant growth rate. The increasing number of transplant operations has contributed to the need for more health centers to respond to the unmet needs of patients. The government is also expected to fuel business demand by increasing organ transplantation support measures. For example, the Health Care and Services Administration Division has financed four grant projects.
Key Players & Strategies
Participants include major global Novartis AG, Medtronic, Pfizer Inc., Sanofi, Preservation Solutions, Inc., TransMedics, Inc., Terumo Corporation, Organ Recovery System, AbbVie Inc., Stryker, Transonic and Others.
Market Segmentation
Organ Transplantation Market By Type
Heart
Kidney
Pancreas
Liver
Others
Organ Transplantation Market By End Use
Transplant Centres
Hospitals
Others
Market By Geography
North America
• U.S.
• Canada
Europe
• U.K.
• Germany
• France
• Spain
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia-Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
CHAPTER 1.Industry Overview of Organ Transplantation
1.1.Definition and Scope
1.1.1.Definition of Organ Transplantation
1.1.2.Market Segmentation
1.1.3.Years Considered for the Study
1.1.4.Assumptions and Acronyms Used
1.1.4.1.Market Assumptions and Market Forecast
1.1.4.2.Acronyms Used in Global Organ Transplantation Market
1.2.Summary
1.2.1.Executive Summary
1.2.2.Organ Transplantation Market By Type
1.2.3.Organ Transplantation Market By End Use
1.2.4.Organ Transplantation Market by Regions
CHAPTER 2.Research Approach
2.1.Methodology
2.1.1.Research Programs
2.1.2.Market Size Estimation
2.1.3.Market Breakdown and Data Triangulation
2.2.Data Source
2.2.1.Secondary Sources
2.2.2.Primary Sources
CHAPTER 3.Market Dynamics And Competition Analysis
3.1.Market Drivers
3.1.1.Driver 1
3.1.2.Driver 2
3.2.Restraints and Challenges
3.2.1.Restrain 1
3.2.2.Restrain 2
3.3.Growth Opportunities
3.3.1.Opportunity 1
3.3.2.Opportunity 2
3.4.Porter’s Five Forces Analysis
3.4.1.Bargaining Power of Suppliers
3.4.2.Bargaining Power of Buyers
3.4.3.Threat of Substitute
3.4.4.Threat of New Entrants
3.4.5.Degree of Competition
3.5.Market Concentration Ratio and Market Maturity Analysis of Organ Transplantation Market
3.5.1.Go To Market Strategy
3.5.1.1.Introduction
3.5.1.2.Growth
3.5.1.3.Maturity
3.5.1.4.Saturation
3.5.1.5.Possible Development
3.6.Technological Roadmap for Organ Transplantation Market
3.7.Value Chain Analysis
3.7.1.List of Key Manufacturers
3.7.2.List of Customers
3.7.3.Level of Integration
3.8.Cost Structure Analysis
3.8.1.Price Trend of Key Raw Materials
3.8.2.Raw Material Suppliers
3.8.3.Proportion of Manufacturing Cost Structure
3.8.3.1.Raw Material
3.8.3.2.Labor Cost
3.8.3.3.Manufacturing Expense
3.9.Regulatory Compliance
3.10.Competitive Landscape, 2020
3.10.1.Player Positioning Analysis
3.10.2.Key Strategies Adopted By Leading Players
CHAPTER 4.Manufacturing Plant Analysis
4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020
4.2.R&D Status and Application Source of Organ Transplantation Major Manufacturers in 2020
CHAPTER 5.Organ Transplantation Market By Type
5.1.Introduction
5.2.Organ Transplantation Revenue By Type
5.2.1.Organ Transplantation Revenue (US$ Mn) and Forecast, By Type, 2017 - 2028
5.2.2.Heart
5.2.2.1.Heart Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.3.Kidney
5.2.3.1.Kidney Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.4.Pancreas
5.2.4.1.Pancreas Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.5.Liver
5.2.5.1.Liver Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
5.2.6.Others
5.2.6.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
CHAPTER 6.Organ Transplantation Market Revenue By End Use
6.1.Introduction
6.2.Organ Transplantation Revenue (US$ Mn) By End Use
6.2.1.Organ Transplantation Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
6.2.2.Transplant Centres
6.2.2.1.Transplant Centres Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.2.3.Hospitals
6.2.3.1.Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
6.2.4.Others
6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017 - 2028
CHAPTER 7.North America Organ Transplantation Market By Country
7.1.North America Organ Transplantation Overview
7.2.U.S.
7.2.1.U.S. Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
7.2.2.U.S. Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
7.3.Canada
7.3.1.Canada Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
7.3.2.Canada Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
7.4.North America PEST Analysis
CHAPTER 8.Europe Organ Transplantation Market By Country
8.1.Europe Organ Transplantation Market Overview
8.2.U.K.
8.2.1.U.K. Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
8.2.2.U.K. Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
8.3.Germany
8.3.1.Germany Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
8.3.2.Germany Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
8.4.France
8.4.1.France Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
8.4.2.France Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
8.5.Spain
8.5.1.Spain Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
8.5.2.Spain Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
8.6.Rest of Europe
8.6.1.Rest of Europe Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
8.6.2.Rest of Europe Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
8.7.Europe PEST Analysis
CHAPTER 9.Asia Pacific Organ Transplantation Market By Country
9.1.Asia Pacific Organ Transplantation Market Overview
9.2.China
9.2.1.China Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
9.2.2.China Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.3.Japan
9.3.1.Japan Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
9.3.2.Japan Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.4.India
9.4.1.India Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
9.4.2.India Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.5.Australia
9.5.1.Australia Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
9.5.2.Australia Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.6.South Korea
9.6.1.South Korea Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
9.6.2.South Korea Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.7.Rest of Asia-Pacific
9.7.1.Rest of Asia-Pacific Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
9.7.2.Rest of Asia-Pacific Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
9.8.Asia Pacific PEST Analysis
CHAPTER 10.Latin America Organ Transplantation Market By Country
10.1.Latin America Organ Transplantation Market Overview
10.2.Brazil
10.2.1.Brazil Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
10.2.2.Brazil Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.3.Mexico
10.3.1.Mexico Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
10.3.2.Mexico Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
10.4.Rest of Latin America
10.4.1.Rest of Latin America Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2016 – 2027
10.4.2.Rest of Latin America Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
CHAPTER 11.Middle East & Africa Organ Transplantation Market By Country
11.1.Middle East & Africa Organ Transplantation Market Overview
11.2.Saudi Arabia
11.2.1.Saudi Arabia Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
11.2.2.Saudi Arabia Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
11.3.UAE
11.3.1.UAE Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
11.3.2.UAE Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
11.4.Rest of Middle East & Africa
11.4.1.Rest of Middle East & Africa Organ Transplantation Market Revenue (US$ Mn) and Forecast By Type, 2017 - 2028
11.4.2.Rest of Middle East & Africa Organ Transplantation Market Revenue (US$ Mn) and Forecast By End Use, 2017 - 2028
CHAPTER 12.Player Analysis Of Organ Transplantation
12.1.Organ Transplantation Market Company Share Analysis
12.2.Competition Matrix
12.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2.New Product Launches and Product Enhancements
12.2.3.Mergers And Acquisition In Global Organ Transplantation Market
12.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13.COMPANY PROFILE
13.1.Novartis AG
13.1.1.Company Snapshot
13.1.2.Business Overview
13.1.3.Financial Overview
13.1.3.1.Revenue (US$ Mn), 2020
13.1.3.2.Novartis AG 2020 Organ Transplantation Business Regional Distribution
13.1.4.Product/ Service and Specification
13.1.5.Recent Developments & Business Strategy
13.1.6.Manufacturing Plant Footprint Analysis
13.2.Medtronic
13.3.Pfizer Inc.
13.4.Sanofi
13.5.Preservation Solutions, Inc.
13.6.TransMedics, Inc.
13.7.Terumo Corporation
13.8.Organ Recovery System
13.9.AbbVie Inc.
13.10.Stryker
13.11.Transonic
13.12.Others